ImageneBio (IMA) Assets Average (2021 - 2025)

ImageneBio has disclosed Assets Average across 5 years of filings, most recently posting $156.9 million for Q4 2025.

• Assets Average for Q4 2025 came in at $156.9 million, up 90.32% year-over-year; the trailing twelve-month figure through Dec 2025 was $156.9 million (up 90.32% YoY), and the FY2025 annual result was $84.4 million, down 18.8% from the prior year.
• Assets Average came in at $156.9 million for Q4 2025 at ImageneBio, up from $143.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $286.2 million in Q2 2021 to a low of $73.4 million in Q1 2025.
• The 5-year median for Assets Average is $181.9 million (2022), against an average of $184.5 million.
• Peak annual rise in Assets Average reached 90.32% in 2025, while the deepest fall reached 59.78% in 2025.
• ImageneBio's Assets Average stood at $254.8 million in 2021, then declined by 28.82% to $181.4 million in 2022, then climbed by 12.32% to $203.7 million in 2023, then tumbled by 59.52% to $82.5 million in 2024, then surged by 90.32% to $156.9 million in 2025.
• The last three Assets Average figures came in at $156.9 million (Q4 2025), $143.5 million (Q3 2025), and $128.5 million (Q2 2025), per Business Quant data.